StockOtters
StockOttersSupply Chain Map
Jiangsu Hengrui Medicine Co., Ltd. logo

Jiangsu Hengrui Medicine Co., Ltd.

600276.SS

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
3,918
Cost of Revenue
543
Gross Profit
3,375
Gross Margin
86.1%
Operating Income
1,049
Operating Margin
26.8%
Net Income
887
Net Margin
22.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1,007
EBITDA Margin
25.7%

2023

12/31/2023

Revenue
3,195
Cost of Revenue
499
Gross Profit
2,696
Gross Margin
84.4%
Operating Income
687
Operating Margin
21.5%
Net Income
602
Net Margin
18.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
678
EBITDA Margin
21.2%

2022

12/31/2022

Revenue
2,979
Cost of Revenue
490
Gross Profit
2,488
Gross Margin
83.5%
Operating Income
576
Operating Margin
19.3%
Net Income
547
Net Margin
18.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
504
EBITDA Margin
16.9%

2021

12/31/2021

Revenue
3,627
Cost of Revenue
526
Gross Profit
3,101
Gross Margin
85.5%
Operating Income
653
Operating Margin
18.0%
Net Income
634
Net Margin
17.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
596
EBITDA Margin
16.4%

2020

12/31/2020

Revenue
3,883
Cost of Revenue
470
Gross Profit
3,413
Gross Margin
87.9%
Operating Income
981
Operating Margin
25.3%
Net Income
886
Net Margin
22.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
941
EBITDA Margin
24.2%